Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Olga Lomovskaya

Evaluation of theIn VitroActivity of Meropenem-Vaborbactam Against Clinical Isolates of KPC-PositiveEnterobacteriaceae

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination With Meropenem

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Assessment of Minocycline and Polymyxin B Combination Against Acinetobacter Baumannii

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Discovery of Cyclic Boronic Acid QPX7728, an Ultra-Broad-Spectrum Inhibitor of Serine and Metallo Beta-Lactamases

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2020English

Potency of Vaborbactam Is Less Affected Than Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2020English

Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella Pneumoniae With Increased Efflux Activity.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam Against Carbapenem-resistantEnterobacteriaceaein an in Vitro Hollow Fiber Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

MexXY-OprM Efflux Pump Is Required for Antagonism of Aminoglycosides by Divalent Cations in Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy